Ligand Pharmaceuticals
LGND
#3601
Rank
$3.63 B
Marketcap
$184.87
Share price
-1.93%
Change (1 day)
48.10%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Total debt

Total debt on the balance sheet as of September 2025 : $0.45 Billion USD

According to Ligand Pharmaceuticals's latest financial reports the company's total debt is $0.45 Billion USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Ligand Pharmaceuticals - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31$7.1 M15.25%
2023-12-31$6.16 M-92.97%
2022-12-31$87.74 M-72.95%
2021-12-31$0.32 B-28.93%
2020-12-31$0.45 B-29.8%
2019-12-31$0.65 B2.18%
2018-12-31$0.63 B183.39%
2017-12-31$0.22 B5.46%
2016-12-31$0.21 B5.41%
2015-12-31$0.20 B3.1%
2014-12-31$0.19 B2050.71%
2013-12-31$9.1 M-67.79%
2012-12-31$28.27 M-6.63%
2011-12-31$30.28 M32.54%
2010-12-31$22.85 M-37%
2009-12-31$36.27 M-29.61%
2008-12-31$51.53 M2291.23%
2007-12-31$2.15 M-94.88%
2006-12-31$42.07 M-75.67%
2005-12-31$0.17 B-0.63%
2004-12-31$0.17 B0.86%
2003-12-31$0.17 B9.66%
2002-12-31$0.15 B10.7%
2001-12-31$0.14 B5.14%
2000-12-31$0.13 B-3.99%
1999-12-31$0.14 B50.27%
1998-12-31$93.7 M72.88%
1997-12-31$54.2 M-4.24%
1996-12-31$56.6 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Amgen
AMGN
$54.58 B 12,003.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
$28.84 M-93.61%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
$23.86 B 5,190.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
$41.37 B 9,073.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$60.84 B 13,391.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$42.50 B 9,325.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$51.04 B 11,217.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
$9.71 B 2,053.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$45.79 B 10,054.17%๐Ÿ‡บ๐Ÿ‡ธ USA